Poseida Therapeutics Inc P-BCMA-ALLO1 Clinical Data Call Transcript
Good day. At this time, I would like to welcome everyone to the Poseidon therapeutics, PDCMALO. one Clinical Data Conference Call. All lines have been placed on mute to prevent any background noise. Sarah Daly, Senior Director, Investor Relations and Corporate Communications. You may begin your conference.
Hello, everyone. Before we begin, I'd like to remind you that today's call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, and we ask that you refer to our filings on SEC.gov, including our most recent quarterly report on Form 10 Q filed with the SEC on November ninth, 2023. For a full list of risks and uncertainties. Actual results may differ materially from those indicated by these statements unless required by law. Safilo does not undertake any obligation to update these statements regarding the future or to conform these statements in relation to actual events.
With that, I will turn the call over to our Chairman and Chief Executive
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |